Chemoradiotherapy in patients with anal cancer: Impact of length of unplanned treatment interruption on outcome

Acta Oncologica

Volumn 45, Issue 6, 2006, Pages 728-735

  Meyer, Andreas ^a   Zueissen, Jurgen Meier ^b   Karstens, Johann H ^a   Bremer, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Sophienklinik Hannover ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; MELPHALAN; MMC PROTOCOL; SEMUSTINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANUS TUMOR; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MELPHALAN; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEMUSTINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247119617     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600726729     Document Type: Article

References (23)

1. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800 (Pubitemid 30151924)
2. Bartelink H, Roelofson F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9 (Pubitemid 27209535)
3. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-54
4. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of Mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39 (Pubitemid 26300120)
5. Cummings BJ, Brierley JD. Anal canal. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology, 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1630-48
6. Graf R, Wust P, Hildebrandt B, Gogler H, Ullrich R, Herrmann R, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003;65:14-22 (Pubitemid 36829086)
7. Deniaud-Alexandre E, Touboul E, Tiret E. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003;56: 1259-73 (Pubitemid 36842877)
8. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974;17:354-6
9. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-Fluorouracil with and without Mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:1115-25
10. Esiashvili N, Landry J, Matthews RH. Carcinoma of the anus: Strategies in management. Oncologist 2002;7:188-99 (Pubitemid 34651221)
11. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-67
12. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051-6
13. Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G. Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: Results of a phase II study. Int J Radiat Oncol Biol Phys 2003;56:823-31 (Pubitemid 36677378)
14. Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001;61:223-31 (Pubitemid 33127227)
15. Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997;37:313-24 (Pubitemid 27138714)
16. Weber DC, Kurtz J, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 2001;50:675-80 (Pubitemid 32519596)
17. Ceresoli GL, Ferreri AJ, Cordio S, Villa E. Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases. Oncology 1998;55:525-32 (Pubitemid 28479110)
18. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM. The impact of treatment factors of local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 1997;79:2329-35 (Pubitemid 27251015)
19. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997;39: 651-7 (Pubitemid 27441432)
20. Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, et al. Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 2003;39:45-51 (Pubitemid 36005424)
21. Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracilcisplatinum. Long-term results in 95 patients. Radiother Oncol 1998;46:249-56 (Pubitemid 28157274)
22. Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, et al. Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index. Cancer 2003;97:1195-202 (Pubitemid 36237304)
23. Peiffert D, Giovannini M, Ducreux M, Michel P, Francois E, Lemanski C, et al. Digestive Tumours Group of the French 'Federation Nationale des Centres de Lutte Contre le Cancer'. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study. Ann Oncol 2001;12: 397-404. (Pubitemid 32288698)